USIran Tensions Snowflake Surge Robinhood AI Morning Market Highlights Exxon Mobil in Talks to ReEnter Venezuela After Nearly Two Decades Reliance Industries Chairman Mukesh Ambani Outlines Vision for AI Energy and Digital Platforms in Indias Growth Era Bitcoin ETFs as Tools for Navigating Crypto Bull Markets A Closer Look Ubisoft Shares Slide After Company Warns of Continued Fiscal Losses Bond Market Signals Inflation Concerns as Warsh Assumes Fed Leadership ATRO Q1 2026 Earnings EPS Beats Estimates Stock Rises Slightly Firefly Neuroscience Inc AIFF Q3 1998 Earnings Steep Earnings Miss as PreRevenue Biotech Faces Cash Burn Headwinds CLSK Q1 2026 Earnings Significant EPS Miss Amid Bitcoin Mining Headwinds AGPU Q1 2025 Earnings Deep Losses and Uncertainty Weigh on Shares After Major EPS Miss Kaiser Aluminum Q1 2026 Earnings Massive EPS Beat Drives Shares Higher Gran Tierra Energy Inc Q4 2025 Earnings Net Loss Reported as Oil Producer Navigates Lower Prices Mohawk Industries Holds Steady Near Key Resistance as Flooring Sector Navigates Demand Uncertainty Natera NTRA Holds Near 203 Modest Decline Signals Cautious Consolidation BristolMyers Squibb BMY Modestly Declines as Resistance Holds Zumiez Inc ZUMZ Surges 444 as Retail Sector Recovers Momentum Darden Restaurants DRI Edges Higher Amid Sector Resilience SK Hynix Surpasses 1 Trillion Valuation as AI Demand Fuels Chip Rally ORC Q1 2026 Earnings Strong EPS Beat Amid Stock Decline Pimco Municipal Income Fund II PML Holds Steady at 743 Amid Tight Trading Range Oxford Industries OXM Q1 2026 Earnings Significant EPS Miss but Shares Rally BJs Wholesale Club Q1 2026 Earnings EPS Beat Amid Market Skepticism Purple Biotech Ltd PPBT Q1 2025 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances Weibo WB Q3 2025 Earnings EPS of 042 as Stock Edges Higher Amid Unclear Revenue Picture Actinium Pharmaceuticals ATNM Q1 2026 Earnings Narrower Loss Beats Expectations as Development Pipeline Advances Guidewire Q1 2026 Earnings EPS Surges Past Estimates by 484 as Operating Performance Strengthens Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares 7